PRESS RELEASE Â Lund Sweden September 5 2018 Active Biotech NASDAQ OMX NORDIC ACTI announced today that it regains the global development and commercialization rights to laquinimod from Teva Pharmaceutical Industries Ltd. Teva's decision to r...
↧